PCSA CIK: 1533743

Processa Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.72
FY22:
−9.61
FY23:
−8.06
FY24:
−11.2
FY25:
−11.4
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
0.00
FY24:
0.00
FY25:
−0.85
Change from FY21 to FY25
millions USD
FY21:
9.80
FY22:
−0.39
FY23:
6.27
FY24:
7.73
FY25:
16.6
millions USD
FY21:
1.08
FY22:
−9.99
FY23:
−1.80
FY24:
−3.51
FY25:
4.35
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−8.07
FY24:
−11.2
FY25:
−12.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data